Quick Answer
HCW Biologics Inc. reported Gross Profit of $10.8 thousand for fiscal year 2025.
HCW Biologics Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $10.8K | -98.9% |
| 2024 | $959.4K | +71.2% |
| 2023 | $560.4K | -78.3% |
| 2022 | $2.59M | — |
| 2021 | $0.00 | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.1K | -96.3% | +138.2% |
| June 30, 2025 | $1.3K | -99.3% | +29.3% |
| March 31, 2025 | $1.0K | -99.8% | -98.8% |
| September 30, 2024 | $85.3K | -51.2% | -52.7% |
| June 30, 2024 | $180.4K | +49.8% | -70.7% |
| March 31, 2024 | $614.7K | +4805.0% | +251.7% |
| September 30, 2023 | $174.8K | -51.7% | +45.2% |
| June 30, 2023 | $120.4K | -27.8% | +860.7% |
- HCW Biologics Inc. showed a decrease of -98.9% in Gross Profit compared to the prior fiscal year.
- The most recent figure is from HCW Biologics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: